Filed before 2025Filed 23 March 2017
OncoResponse Inc has sold $29.5M so far
OncoResponse Inc, a biotech company based in Seattle, WA, has sold $29.5M so far in its equity round, according to a filing dated 23 March 2017.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 23 March 2017
- First filed
- 15 October 2015
- Round
- Equity round (amended filing)
- Amount sold
- $29.5M
- Offering size
- $34M
- Investors so far
- 12
- Based in
- Seattle, WA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 88% of the 1,645 tracked raises with an amount filed in 2017, and than 76% of the 152 in biotech.
OncoResponse, Inc in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 6 May 2025 | New filing | $6M | Another raise |
| 12 May 2023 | New filing | $13.9M | Another raise |
| 31 Mar 2021 | New filing | $40.6M | Another raise |
| 6 Sep 2018 | New filing | $19M | Another raise |
| 23 Mar 2017 | Amended filing | $29.5M | This raise |
| 26 May 2016 | Amended filing | $19.5M | This raise |
More with GreatPoint Ventures Innovation on the board
- Biobot Analytics, Inc.$13.5M
- Linus Biotechnology Inc.$6.15M
- Invicta Medical, Inc.$25M
- Mythic Inc.$20.5M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.